Pattern Interpretation in NCS
- 1Assemble axonal, demyelinating, and mixed NCS patterns from first principles
- 2Localize focal entrapment by segmental slowing and conduction block
- 3Interpret velocity in the context of amplitude to avoid axonal pseudo-slowing
Individual nerve conduction parameters are diagnostically inert in isolation; their meaning emerges only from the pattern they form across nerves, segments, and modalities. Pattern interpretation is the act of collapsing a tableau of latencies, amplitudes, and velocities into a single mechanistic read — axonal or demyelinating, uniform or multifocal, focal or generalised — and then weighting that read by prior probability until it converges on a diagnosis. This is the synthetic skill that separates a technician who measures from an electromyographer who interprets.
The axonal pattern
Axonal degeneration removes whole conducting units, so its electrophysiological signature is dominated by amplitude. The defining tetrad is low CMAP and SNAP amplitude with relatively preserved conduction velocity and distal latency, because the surviving axons conduct normally — the lesion subtracts fibres rather than slowing them. Velocity holds near normal until the fastest, largest-diameter fibres are themselves lost, at which point it falls modestly and secondarily (the amplitude-dependent slowing rule). The hallmark distribution is length-dependent: the longest axons die back first, so sensory responses in the feet (sural, superficial peroneal) and distal motor amplitudes degrade before more proximal nerves, producing the symmetric distal gradient of the prototypical dying-back polyneuropathy.
The demyelinating pattern
Demyelination degrades the insulation that makes saltatory conduction fast and reliable, so its signature is dominated by timing and conduction failure rather than fibre count. The features cluster as: slowed conduction velocity (often below 70–80% of the lower limit), prolonged distal latency (above ~125–150% of the upper limit, reflecting terminal demyelination), prolonged, dispersed, or absent F-waves (proximal involvement), and, in acquired forms, the two phenomena that are the most specific signs available to the discipline — conduction block and temporal dispersion. Amplitude on distal stimulation is comparatively preserved unless block or dispersion intervenes, which is the cardinal contrast with the axonal pattern.
The distribution of slowing distinguishes inherited from acquired demyelination. Uniform slowing — every segment of every nerve slowed to a similar degree, with no block and little dispersion — reflects a genetically uniform myelin defect and is the fingerprint of inherited demyelinating neuropathy (CMT1). Multifocal slowing — patchy slowing with conduction block and temporal dispersion at non-entrapment sites — reflects an immune attack that strikes some internodes and spares others, and is the fingerprint of acquired demyelination (CIDP, MMN, GBS). Block and dispersion are essentially never inherited; their presence reclassifies a demyelinating study as acquired.
Drag calipers A and B onto the two onsets to measure conduction velocity across the forearm segment.
Focal entrapment and short-segment studies
Entrapment neuropathy produces focal, segmental slowing confined to the compressed stretch of nerve, against a background of normal conduction above and below. Across a long routine segment this focal slowing is diluted — a few centimetres of slow conduction averaged into twenty of normal conduction may barely move the velocity — which is why focal lesions demand short-segment incremental studies ("inching"). Stimulating at 1–2 cm intervals across the suspected site localises the lesion to the internode where a discrete latency jump or amplitude/configuration change appears, as in ulnar neuropathy across the elbow or median neuropathy at the wrist. The trade-off is measurement noise: over a 1 cm segment, a fraction-of-a-millisecond latency error translates into a large apparent velocity, so inching requires meticulous distance measurement and favours latency increments over computed velocities.
Mixed neuropathies and the amplitude-dependent slowing rule
Real neuropathies are frequently mixed, combining axon loss with demyelination, and the interpretive danger is double-counting. The cardinal rule that disciplines every read is that severe axon loss itself slows conduction velocity, by removing the fastest, largest-diameter fibres and leaving the examiner timing the slow survivors. A velocity must therefore always be interpreted against the amplitude that produced it: mild slowing accompanying a markedly reduced CMAP is axonal slowing and does not license a demyelinating label, whereas slowing that is disproportionate to axon loss — a CV below 70–80% of the lower limit with a preserved amplitude — is the genuine demyelinating range. Conduction block and temporal dispersion cannot be produced by axon loss at all, so their presence is the cleanest evidence of an acquired demyelinating component within a mixed picture.
- Axonal pattern: low CMAP/SNAP amplitude with relatively preserved CV and latency, length-dependent — the lesion subtracts fibres, not speed.
- Demyelinating pattern: slow CV, prolonged distal latency, prolonged/absent F-waves, and (in acquired disease) conduction block and temporal dispersion.
- Uniform slowing without block = inherited (CMT1); multifocal slowing with block/dispersion = acquired (CIDP, MMN, GBS).
- Focal entrapment causes segmental slowing best localised by short-segment inching (latency increments over computed velocities).
- Severe axon loss slows CV — always read velocity against amplitude — and synthesise all parameters into one Bayesian read rather than anchoring on a single number.
- 1.Preston DC, Shapiro BE. Electromyography and Neuromuscular Disorders: Clinical-Electrophysiologic-Ultrasound Correlations. 4th ed. Elsevier; 2021: Ch. 3–4, 26.
- 2.Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 4th ed. Oxford University Press; 2013.
- 3.AANEM/EFNS. Electrodiagnostic criteria for the demyelinating polyneuropathies (CIDP, MMN, GBS). Muscle Nerve; J Peripher Nerv Syst.
- 4.Van den Bergh PYK, et al. EFNS/PNS guideline on the diagnosis of CIDP. J Peripher Nerv Syst. 2021;26:242–268.